NO972467D0 - Transdermal system for samtidig avgivelse av et antall aktive bestanddeler - Google Patents

Transdermal system for samtidig avgivelse av et antall aktive bestanddeler

Info

Publication number
NO972467D0
NO972467D0 NO972467A NO972467A NO972467D0 NO 972467 D0 NO972467 D0 NO 972467D0 NO 972467 A NO972467 A NO 972467A NO 972467 A NO972467 A NO 972467A NO 972467 D0 NO972467 D0 NO 972467D0
Authority
NO
Norway
Prior art keywords
amount
pct
therapeutic dose
effective therapeutic
active ingredients
Prior art date
Application number
NO972467A
Other languages
English (en)
Other versions
NO972467L (no
Inventor
Bruno Bevan
Cecile Aillaud
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of NO972467D0 publication Critical patent/NO972467D0/no
Publication of NO972467L publication Critical patent/NO972467L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO972467A 1994-12-21 1997-05-30 Transdermal system for samtidig avgivelse av et antall aktive bestanddeler NO972467L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs
PCT/FR1995/001696 WO1996019203A1 (fr) 1994-12-21 1995-12-19 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (2)

Publication Number Publication Date
NO972467D0 true NO972467D0 (no) 1997-05-30
NO972467L NO972467L (no) 1997-06-17

Family

ID=9470067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972467A NO972467L (no) 1994-12-21 1997-05-30 Transdermal system for samtidig avgivelse av et antall aktive bestanddeler

Country Status (23)

Country Link
US (1) US5919477A (no)
EP (1) EP0800386B1 (no)
JP (1) JPH10510823A (no)
KR (1) KR980700071A (no)
CN (1) CN1072929C (no)
AT (1) ATE173164T1 (no)
AU (1) AU692042B2 (no)
CA (1) CA2208374A1 (no)
CZ (1) CZ183297A3 (no)
DE (1) DE69506007T2 (no)
DK (1) DK0800386T3 (no)
ES (1) ES2125679T3 (no)
FI (1) FI972542A7 (no)
FR (1) FR2728463A1 (no)
HU (1) HUT77384A (no)
NO (1) NO972467L (no)
NZ (1) NZ298826A (no)
PL (1) PL182452B1 (no)
RU (1) RU2157193C2 (no)
SI (1) SI0800386T1 (no)
SK (1) SK280631B6 (no)
UA (1) UA42806C2 (no)
WO (1) WO1996019203A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298590T1 (de) 1998-04-27 2005-07-15 Surmodics Inc Bioaktive wirkstoffe freisetzende beschichtungen
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7243788B2 (en) * 2003-10-22 2007-07-17 Kimberly-Clark Worldwide, Inc. Package for segregating and mixing substances
NZ546992A (en) * 2003-10-28 2009-07-31 Noven Pharma Transdermal drug delivery device
US20050220842A1 (en) * 2004-04-06 2005-10-06 Dewitt David M Coating compositions for bioactive agents
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
FI972542L (fi) 1997-06-16
HUT77384A (hu) 1998-04-28
DE69506007D1 (de) 1998-12-17
FR2728463B1 (no) 1997-02-21
JPH10510823A (ja) 1998-10-20
DK0800386T3 (da) 1999-07-26
AU692042B2 (en) 1998-05-28
CN1072929C (zh) 2001-10-17
DE69506007T2 (de) 1999-06-10
FR2728463A1 (fr) 1996-06-28
SK280631B6 (sk) 2000-05-16
FI972542A0 (fi) 1997-06-16
HK1004375A1 (en) 1998-11-27
UA42806C2 (uk) 2001-11-15
EP0800386A1 (fr) 1997-10-15
FI972542A7 (fi) 1997-06-16
WO1996019203A1 (fr) 1996-06-27
MX9704527A (es) 1997-10-31
SI0800386T1 (en) 1999-04-30
NO972467L (no) 1997-06-17
SK79197A3 (en) 1997-12-10
CN1170359A (zh) 1998-01-14
US5919477A (en) 1999-07-06
CA2208374A1 (en) 1996-06-27
ATE173164T1 (de) 1998-11-15
CZ183297A3 (en) 1997-10-15
KR980700071A (ko) 1998-03-30
ES2125679T3 (es) 1999-03-01
AU4450596A (en) 1996-07-10
NZ298826A (en) 1998-10-28
PL320883A1 (en) 1997-11-10
PL182452B1 (pl) 2002-01-31
RU2157193C2 (ru) 2000-10-10
EP0800386B1 (fr) 1998-11-11

Similar Documents

Publication Publication Date Title
NO972467D0 (no) Transdermal system for samtidig avgivelse av et antall aktive bestanddeler
BG103552A (bg) Терапевтични средства
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
NO20064395L (no) Anvendelse av buprenorfin i fremstilling av et medikament
ATE190225T1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
ZA95741B (en) Therapeutic agents
DK0799024T3 (da) Farmaceutisk aerosol indeholdende mindst en sukker
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
MXPA02008403A (es) Mejoras en o relacionadas con el suministro de farmacos por via oral.
DK0586621T3 (da) Linsidomin til behandling af erektile dysfunktioner
IL108234A0 (en) Pharmaceutical composition containing galanthamine
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE69814669D1 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
HUP9701051A2 (hu) Természetes hatóanyagú, gyógyhatású készítmények

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application